Literature DB >> 1787128

Review of quinolones in the treatment of infections of the skin and skin structure.

L O Gentry1.   

Abstract

The oral fluoroquinolones ciprofloxacin, ofloxacin and temafloxacin are active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa. Ciprofloxacin has been extensively studied, and is as effective as parenteral third-generation cephalosporins in many difficult infections of the skin and skin structure. Ofloxacin has been less extensively studied, yet is probably more effective than ciprofloxacin against Staphylococcus aureus, while less effective against P. aeruginosa. Temafloxacin is an oral quinolone, and appears to be a promising agent for skin and soft tissue infections due to its extended spectrum of activity, including anaerobic pathogens. Oral fluoroquinolone monotherapy, when combined with surgical debridement and local management, may be effective in many difficult infections of the skin and skin structure previously treated with parenteral antibiotics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1787128     DOI: 10.1093/jac/28.suppl_c.97

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  9 in total

Review 1.  The appropriate use of quinolones.

Authors:  A Percival
Journal:  Drugs       Date:  1996       Impact factor: 9.546

2.  Clinafloxacin versus piperacillin-tazobactam in treatment of patients with severe skin and soft tissue infections.

Authors:  G Siami; N Christou; I Eiseman; K J Tack
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

3.  Intravenous or sequential ciprofloxacin therapy in hospitalised patients with a broad spectrum of infections: a post-marketing surveillance study.

Authors:  H Koch; H Landen; K Stauch
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 4.  A practical guide to the treatment of complicated skin and soft tissue infections.

Authors:  Horatio B Fung; Joanne Y Chang; Stephen Kuczynski
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Newer treatment options for skin and soft tissue infections.

Authors:  Murugan Raghavan; Peter K Linden
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  The Role of Fluoroquinolones in the Treatment of Skin and Soft Tissue Infection.

Authors:  Md Rabiul Alam; Ellie Hershberger; Marcus J. Zervos
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 7.  Activity of quinolones against gram-positive cocci: clinical features.

Authors:  H Giamarellou
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 8.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

9.  Efficacies of ABT-719 and related 2-pyridones, members of a new class of antibacterial agents, against experimental bacterial infections.

Authors:  J Alder; J Clement; J Meulbroek; N Shipkowitz; M Mitten; K Jarvis; A Oleksijew; T Hutch; L Paige; B Flamm
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.